咯血是临床常见的急症之一,其原发病因多种多样,在积极治疗原发病的基础上需及时处理咯血。以往咯血的治疗常首选垂体后叶素,自20世纪80年代起,扩血管药物酚妥拉明逐渐应用于临床治疗咯血,取得了较好的效果。本文总结我院自1995年以来,内科病区收治的咯血病人86例,观察应用酚妥拉明的治疗效果,并与垂体后叶素的疗效作一对比。 Hemoptysis is one of the common clinical emergency, the primary cause of a variety of active treatment of primary disease on the basis of timely treatment of hemoptysis. Past hemoptysis treatment often preferred pituitrin, since the 1980s, vasopressin vasodilator drug gradually applied to the clinical treatment of hemoptysis, and achieved good results. This article summarizes our hospital since 1995, medical ward treated patients with hemoptysis in 86 cases, observed the application of phentolamine treatment effect, and the efficacy of pituitrin for a comparison.